International Conference on Cell Biology and Radiobiology 2016, Brno
The International Conference on Cell Biology and Radiobiology – The Satellite Conference to the 6th International Conference on Genomics & Pharmacogenomics (held in Berlin, Germany, in September 12th – 14th, 2016) – is organized by the Institute of Biophysics, v.v.i., in Brno in 8th – 10th September 2016.
The conference is focused on the most recent advances and applications in different fields of cell biology and radiobiology; especially those linked to cancer pathogenesis, cancer treatment, current and future radiation risks, and associated methodology.
Our prominent speakers,
Prof. Michael Hausmann, PhD., from the Kirchhoff Institute for Physics (Heidelberg, Germany)
Prof. Roger Martin, PhD., from the Peter MacCallum Cancer Centre (Melbourne, Australia)
Ing. Marie Davidkova, PhD., from the Institute of Nuclear Physics, CAS (Prague, Czech Republic)
and Assoc. Prof. Alena Furdova, PhD., from the University Hospital in Bratislava, Slovak Republic,
will present their lectures on challenges in superresolution microscopy (nanoscopy), new strategies in radioprotection, biological effects of protons and heavy ions (ion-beam cancer therapy), and complications associated with radiosurgery and mutagenesis associated with cancer. With its current resolution power of up to 10 nm in spatially fixed cells (or even living cells in future), nanoscopy will take us on an exciting journey through the newly emerging cell 'nanocosmos'. On the other hand, serious health risks due to cosmic radiation exposure still preclude our planned interplanetary trips within the macrocosmos. Successful development of efficient but non-toxic radioprotectives will be therefore a substantial step forward in astronautics; however, it also represents a principal goal in public protection and radiotherapy. In the latter case, radiodamage to normal tissue in tumor vicinity limits the efficiency and applicability of radiotherapy. Proton and ion-beam cancer therapy then poses another promising way (in addition to radioprotectives application) of how to limit unwanted damage to normal tissues and kill tumor cells even more efficiently at the same time.